Cargando…

Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression

The application of tumor immunotherapy to glioblastoma (GBM) is limited by an unprecedented degree of immune suppression due to factors that include high numbers of immune suppressive myeloid cells, the blood brain barrier, and T cell sequestration to the bone marrow. We previously identified an inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alban, Tyler J., Bayik, Defne, Otvos, Balint, Rabljenovic, Anja, Leng, Lin, Jia-Shiun, Leu, Roversi, Gustavo, Lauko, Adam, Momin, Arbaz A., Mohammadi, Alireza M., Peereboom, David M., Ahluwalia, Manmeet S., Matsuda, Kazuko, Yun, Kyuson, Bucala, Richard, Vogelbaum, Michael A., Lathia, Justin D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315581/ https://www.ncbi.nlm.nih.gov/pubmed/32625208 http://dx.doi.org/10.3389/fimmu.2020.01191

Ejemplares similares

IL-11 drives postsurgical hepatocellular carcinoma recurrence
por: Lauko, Adam, et al.
Publicado: (2019)

The MIF promoter SNP rs755622 is associated with immune activation in glioblastoma
por: Alban, Tyler J., et al.
Publicado: (2023)

OTEH-2. High-dimensional analysis of spatial immune cell heterogeneity in glioblastoma reveals differences between contrast-enhancing and non-contrast-enhancing tumor rims
por: Watson, Dionysios C, et al.
Publicado: (2021)

Spatial immunosampling of MRI-defined glioblastoma regions reveals immunologic fingerprint of non-contrast enhancing, infiltrative tumor margins
por: Grabowski, Matthew M., et al.
Publicado: (2023)

Interrogating the interactions between myeloid derived suppressor cells and cancer stem cells in glioblastoma
por: Otvos, Balint, et al.
Publicado: (2013)

Distinct Cell Adhesion Signature Defines Glioblastoma Myeloid-Derived Suppressor Cell Subsets
por: Bayik, Defne, et al.
Publicado: (2022)

Hepatobiliary malignancies have distinct peripheral myeloid-derived suppressor cell signatures and tumor myeloid cell profiles
por: Bayik, Defne, et al.
Publicado: (2020)

Release the ballast: Glioblastoma rises above radiation therapy by exporting miR-603 in extracellular vesicles to become treatment-resistant
por: Bayik, Defne, et al.
Publicado: (2020)

The missing link? LGMN connects hypoxia and immunosuppression in glioblastoma
por: Mitchell, Jonathan, et al.
Publicado: (2023)

Medical management of brain metastases
por: Lauko, Adam, et al.
Publicado: (2020)

SerpinB3 drives cancer stem cell survival in glioblastoma
por: Lauko, Adam, et al.
Publicado: (2022)

Factors Influencing the Differentiation of Human Monocytic Myeloid-Derived Suppressor Cells Into Inflammatory Macrophages
por: Bayik, Defne, et al.
Publicado: (2018)

Brain metastasis and treatment
por: Ahluwalia, Manmeet S., et al.
Publicado: (2014)

RADI-35. AN ANALYSIS OF RESPONSE ENDPOINTS FOR BRAIN METASTASIS PATIENTS TREATED WITH STEREOTACTIC RADIOSURGERY AND PD(L)-1 INHIBITORS
por: Kotecha, Rupesh, et al.
Publicado: (2019)

THER-02. IMPACT OF SYSTEMIC THERAPY IN MELANOMA BRAIN METASTASIS
por: Sagar, Soumya, et al.
Publicado: (2019)

THER-13. IMMUNOTHERAPY VERSUS STANDARD OF CARE IN MELANOMA BRAIN METASTASES WITH KNOWN BRAF STATUS
por: Barnett, Addison, et al.
Publicado: (2019)

THER-10. IMPACT OF BRAF MUTATIONAL STATUS ON THE EFFICACY OF IMMUNOTHERAPY FOR MELANOMA BRAIN METASTASES
por: Lauko, Adam, et al.
Publicado: (2019)

Sex-Biased T-cell Exhaustion Drives Differential Immune Responses in Glioblastoma
por: Lee, Juyeun, et al.
Publicado: (2023)

Novel Therapeutic Approaches in Neoplastic Meningitis
por: Khosla, Atulya Aman, et al.
Publicado: (2022)

THER-09. IMPACT OF KRAS MUTATION STATUS ON THE EFFICACY OF IMMUNOTHERAPY IN LUNG CANCER BRAIN METASTASES
por: Lauko, Adam, et al.
Publicado: (2019)

THER-16. EFFICACY OF UPFRONT IMMUNE CHECKPOINT INHIBITORS IN LUNG CANCER BRAIN METASTASIS
por: Barnett, Addison, et al.
Publicado: (2019)

EGFR Pathway Expression Persists in Recurrent Glioblastoma Independent of Amplification Status
por: Dhawan, Andrew, et al.
Publicado: (2023)

THER-14. INFLUENCE OF CLINICAL PARAMETERS ON THE EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER BRAIN METASTASES (NSCLCBM)
por: Lauko, Adam, et al.
Publicado: (2019)

OTME-10. Integrated analysis of human gliomas at the single cell level identifies S100A4 as a novel immunotherapy target
por: Abdelfattah, Nourhan, et al.
Publicado: (2021)

Coiled-Coil Domain Containing Protein 124 Is a Novel Centrosome and Midbody Protein That Interacts with the Ras-Guanine Nucleotide Exchange Factor 1B and Is Involved in Cytokinesis
por: Telkoparan, Pelin, et al.
Publicado: (2013)

MBOAT7-driven phosphatidylinositol remodeling promotes the progression of clear cell renal carcinoma
por: Neumann, Chase K.A., et al.
Publicado: (2020)

Surgical Site Infection Prophylaxis and Wound Management in Spine Surgery
por: White, Alexandra J., et al.
Publicado: (2022)

Development of a Cx46 Targeting Strategy for Cancer Stem Cells
por: Mulkearns-Hubert, Erin E., et al.
Publicado: (2019)

The Translocator Protein (TSPO) Genetic Polymorphism A147T Is Associated with Worse Survival in Male Glioblastoma Patients
por: Troike, Katie M., et al.
Publicado: (2021)

RADI-25. REPEAT STEREOTACTIC RADIOSURGERY FOR RECURRENT BRAIN METASTASES
por: Krivosheya, Daria, et al.
Publicado: (2019)

First follow‐up radiographic response is one of the predictors of local tumor progression and radiation necrosis after stereotactic radiosurgery for brain metastases
por: Sharma, Mayur, et al.
Publicado: (2017)

TRLS-05. EARLY RESULTS FROM A PROSPECTIVE PHASE I/II DOSE ESCALATION STUDY OF NEOADJUVANT RADIOSURGERY FOR BRAIN METASTASES
por: Murphy, Erin, et al.
Publicado: (2019)

Transferred mitochondria accumulate reactive oxygen species, promoting proliferation
por: Kidwell, Chelsea U, et al.
Publicado: (2023)

Progress on Antiangiogenic Therapy for Patients with Malignant Glioma
por: Ahluwalia, Manmeet S., et al.
Publicado: (2010)

Targeted therapy of brain metastases: latest evidence and clinical implications
por: Di Lorenzo, Rodica, et al.
Publicado: (2017)

First- versus Third-Generation EGFR Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases
por: Tatineni, Vineeth, et al.
Publicado: (2023)

Endoglin inhibitor TRC105 with or without bevacizumab for bevacizumab-refractory glioblastoma (ENDOT): a multicenter phase II trial
por: Ahluwalia, Manmeet S., et al.
Publicado: (2023)

Open sternum, cooler heart: The effect of surgical approach on myocardial temperature
por: Momin, Arbaz A., et al.
Publicado: (2020)

Computer-assisted design/computer-assisted manufacturing systems: A revolution in restorative dentistry
por: Sajjad, Arbaz
Publicado: (2016)

Identifying conserved molecular targets required for cell migration of glioblastoma cancer stem cells
por: Volovetz, Josephine, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j976ncp9r096vldmj86ee3cuol